Antiretroviral Therapy, Highly Active

Virology
Use of Acyclovir for Suppression of Human Immunodeficiency Virus Infection Is Not Associated with Genotypic Evidence of Herpes Simplex Virus Type 2 Resistance to Acyclovir: Analysis of Specimens from Three Phase III Trials
Deborah Watson-Jones, Anna Wald, Connie Celum, Jairam Lingappa, Helen A. Weiss, John Changalucha, Kathy Baisley, Clare Tanton, Richard J. Hayes, Joshua O. Marshak, Rula Green Gladden, David M. Koelle
Virology
Switching of Inferred Tropism Caused by HIV during Interruption of Antiretroviral Therapy
L. Sarmati, S. G. Parisi, C. Andreoni, E. Nicastri, A. R. Buonomini, C. Boldrin, L. Dori, M. Montano, C. Tommasi, S. Andreis, V. Vullo, G. Palù, M. Andreoni
Virology
Detection of HIV-1 at between 20 and 49 Copies per Milliliter by the Cobas TaqMan HIV-1 v2.0 Assay Is Associated with Higher Pretherapy Viral Load and Less Time on Antiretroviral Therapy
José F. Pascual-Pareja, Lorena Martínez-Prats, Joanna Luczkowiak, Silvana Fiorante, Rafael Rubio, Federico Pulido, Joaquín R. Otero, Rafael Delgado
Virology
Determining Seminal Plasma Human Immunodeficiency Virus Type 1 Load in the Context of Efficient Highly Active Antiretroviral Therapy
Christophe Pasquier, Karine Sauné, Stéphanie Raymond, Nathalie Moinard, Myriam Daudin, Louis Bujan, Jacques Izopet
Virology
Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant Variants
Sabelle Jallow, Abraham Alabi, Ramu Sarge-Njie, Kevin Peterson, Hilton Whittle, Tumani Corrah, Assan Jaye, Matthew Cotten, Guido Vanham, Samuel J. McConkey, Sarah Rowland-Jones, Wouter Janssens
Virology
High Prevalence of Multiple Human Herpesviruses in Saliva from Human Immunodeficiency Virus-Infected Persons in the Era of Highly Active Antiretroviral Therapy
Craig S. Miller, Joseph R. Berger, Yunanan Mootoor, Sergei A. Avdiushko, Hua Zhu, Richard J. Kryscio
Virology
Association between Cellular Human Immunodeficiency Virus DNA Level and Immunological Parameters in Patients with Undetectable Plasma Viremia Level during Highly Active Antiretroviral Therapy
Loredana Sarmati, Saverio Giuseppe Parisi, Emanuele Nicastri, Gabriella d'Ettorre, Lucia Palmisano, Mauro Andreotti, Carolina Andreoni, Marina Giuliano, Francesca Gatti, Caterina Boldrin, Giorgio Palù, Vincenzo Vullo, Stefano Vella, Massimo Andreoni
Virology
Decay of Human Immunodeficiency Virus Type 1 Unintegrated DNA Containing Two Long Terminal Repeats in Infected Individuals after 3 to 8 Years of Sustained Control of Viremia
Jennifer L. McDermott, Isabella Martini, Davide Ferrari, Francesca Bertolotti, Claudio Giacomazzi, Giuseppe Murdaca, Francesco Puppo, Francesco Indiveri, Oliviero E. Varnier
Virology
Dissociation of Serum and Liver Hepatitis C Virus RNA Levels in Patients Coinfected with Human Immunodeficiency Virus and Treated with Antiretroviral Drugs
Milena Furione, Renato Maserati, Marta Gatti, Fausto Baldanti, Agostino Cividini, Raffaele Bruno, Giuseppe Gerna, Mario U. Mondelli
Virology
High Prevalence of M184 Mutation among Patients with Viroimmunologic Discordant Responses to Highly Active Antiretroviral Therapy and Outcomes after Change of Therapy Guided by Genotypic Analysis
Emanuele Nicastri, Loredana Sarmati, Gabriella d'Ettorre, Saverio G. Parisi, Lucia Palmisano, Clementina Galluzzo, Marco Montano, Ilaria Uccella, Roberta Amici, Francesca Gatti, Vincenzo Vullo, Ercole Concia, Stefano Vella, Massimo Andreoni

Main menu

User menu

Search

Antiretroviral Therapy, Highly Active

Pages